Skip to main content
SpringerLink
Log in

Anagrelide/aspirin/hydroxycarbamide

Lack of efficacy and major bleeding: 5 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Santaliestra M, et al. Review of the risk of thrombosis or bleeding upon abrupt anagrelide discontinuation in patients with essential thrombocythemia. Annals of Hematology 101: 2563-2564, No. 11, Nov 2022. Available from: URL: http://doi.org/10.1007/s00277-022-04956-y

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anagrelide/aspirin/hydroxycarbamide. Reactions Weekly 1942, 24 (2023). https://doi.org/10.1007/s40278-023-32633-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-32633-5

Search

Navigation